EUVIMEDEUVIMED entdecken
Open Access

Central Haemodynamic Abnormalities and Outcome in Patients with Unexplained Dyspnoea

Kazunori Omote, Frederik H Verbrugge, Hidemi Sorimachi, Massar Omar, Dejana Popovic, Masaru Obokata, Yogesh N V Reddy, Barry A Borlaug

European Journal of Heart Failure · 01.02.2023 · 25 (2) · 185-196

DOI: 10.1002/ejhf.2747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 15.12.2022. Verfasst von Kazunori Omote und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHLBI, United States Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Little data are available regarding prognostic implications of invasive exercise testing in heart failure with preserved ejection fraction (HFpEF). The present study aimed to investigate whether rest and exercise central haemodynamic abnormalities are associated with adverse clinical outcomes in patients with dyspnea. Methods and results Patients with exertional dyspnoea and ejection fraction ≥50% (n = 764) underwent invasive exercise testing and follow-up for heart failure hospitalization or death. There were 117 patients with events over a median follow-up of 2.7 (interquartile range 0.5–4.6) years. Among patients with normal resting pulmonary artery wedge pressure (PAWP) (<15 mmHg, n = 380 [50%]), increased exercise PAWP (≥25 mmHg) was present in 187 (24% of cohort) and was associated with 2.4-fold higher risk of events compared to those with normal exercise PAWP (<25 mmHg, n = 193 [25%]) (hazard ratio [HR] 2.44; 95% confidence interval [CI] 1.11–5.36; p = 0.03), while patients with elevated resting PAWP (≥15 mmHg, n = 384 [50%]) displayed even higher risk compared to HFpEF with normal resting PAWP (HR 2.24; 95% CI 1.38–3.65; p = 0.001). Similar findings were observed for rest/exercise right atrial pressure, and rest/exercise pulmonary artery pressures. Higher peak oxygen consumption was associated with decreased risk of events, and this relationship was solely explained by exercise cardiac output. In a multivariable-adjusted Cox model, each 1 standard deviation (SD) increase in exercise PAWP was associated with a 41% greater hazard of events (HR 1.41; 95% CI 1.13–1.76; p = 0.002), while each 1 SD decrease in exercise cardiac output was associated with a 37% increased risk (HR 0.63; 95% CI 0.47–0.83; p = 0.001).

Conclusions

Haemodynamic abnormalities currently used for diagnosis of HFpEF are associated with increased risk for adverse events. Treatments that reduce central pressures while improving cardiac output reserve may offer greatest benefit to improve outcomes in HFpEF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHumansStroke VolumeHemodynamicsDyspneaCardiac CatheterizationExercise Test

Stichwörter der Autor:innen

Exercise haemodynamicsHeart failureHeart failure with preserved ejection fractionInvasive haemodynamicsOutcome

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Centre for Cardiovascular Diseases, University Hospital Brussels, Jette, Belgium.
  • Faculty of Medicine and Life Sciences, Biomedical Research Institute, Hasselt University, Hasselt, Belgium.

Förderung

  • NHLBI NIH HHS
  • NHLBI
  • United States Department of Defense
  • Uehara Memorial Foundation, Japan
  • Japan Heart Foundation
  • Japan Society for the Promotion of Science
  • Belgian American Educational Foundation
  • Bijzonder Onderzoeksfonds UGent

Zitieren

APA

Omote, K., Verbrugge, F. H., Sorimachi, H., Omar, M., Popovic, D., Obokata, M., Reddy, Y. N. V., & Borlaug, B. A. (2023). Central Haemodynamic Abnormalities and Outcome in Patients with Unexplained Dyspnoea. European Journal of Heart Failure, 25(2), 185-196. https://doi.org/10.1002/ejhf.2747

Vancouver

Omote K, Verbrugge FH, Sorimachi H, Omar M, Popovic D, Obokata M, et al. Central Haemodynamic Abnormalities and Outcome in Patients with Unexplained Dyspnoea. European Journal of Heart Failure. 2023;25(2):185-196. doi:10.1002/ejhf.2747

BibTeX
@article{Omote2023,
  author = {Omote, Kazunori and Verbrugge, Frederik H and Sorimachi, Hidemi and Omar, Massar and Popovic, Dejana and Obokata, Masaru and Reddy, Yogesh N V and Borlaug, Barry A},
  title = {Central Haemodynamic Abnormalities and Outcome in Patients with Unexplained Dyspnoea},
  journal = {European Journal of Heart Failure},
  year = {2023},
  volume = {25},
  number = {2},
  pages = {185--196},
  doi = {10.1002/ejhf.2747}
}
Kostenlos starten →